Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Heathrow to pay dividend as profit, passenger numbers soar

(Sharecast News) - London's Heathrow airport on Wednesday reported a surge in annual profit, record passenger numbers and declared a dividend for the first time since the Covid-19 pandemic. Pre-tax profit at the west London airport surged by 31% to £917m last year, with a 6% year-on-year rise in passengers to 83.9 million. Shareholders will share a £250m dividend.

Revenues fell 3.5% to £3.56bn and underlying earnings were 8.7% lower at £2.04bn. Heathrow cited lower charges paid by airlines, set by regulator the Civil Aviation Authority, for the declines.

The results come after the government resurrected plans for a third runway at the airport, despite fierce opposition to the proposal in the past that saw it shelved.

Heathrow chief executive Thomas Woldbye said securing future economic growth "means investing in the infrastructure that powers it".

He added that the airport would make "the largest private investment in the UK's transport network" over the next 10 years to create "a competitive world-class hub fit for the future".

In December 2024, French company Ardian completed a deal to become Heathrow's largest shareholder with a 23% stake, while Saudi Arabia's sovereign wealth fund purchased a 15% share after Spain's Ferrovial - which had been the airport's largest shareholder since 2006 - sold the majority of its 25% stake, and sales by other shareholders.

Heathrow's other owners include sovereign wealth funds from Qatar and China, and large infrastructure funds.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.